MGMT and glioblastoma: To directly determine whether the enhancer was essential for MGMT expression, we used the CRISPR/Cas9 system37 to delete a 3.3 kb region (chr10: 130,704,894–130,708,206) in the MGMT-expressing SKMG3 glioblastoma cell line (Fig. 5a).